These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 31204278)
1. The deubiquitinase USP13 stabilizes the anti-inflammatory receptor IL-1R8/Sigirr to suppress lung inflammation. Li L; Wei J; Li S; Jacko AM; Weathington NM; Mallampalli RK; Zhao J; Zhao Y EBioMedicine; 2019 Jul; 45():553-562. PubMed ID: 31204278 [TBL] [Abstract][Full Text] [Related]
2. IL-37-induced activation of glycogen synthase kinase 3β promotes IL-1R8/Sigirr phosphorylation, internalization, and degradation in lung epithelial cells. Li L; Wei J; Suber TL; Ye Q; Miao J; Li S; Taleb SJ; Tran KC; Tamaskar AS; Zhao J; Zhao Y J Cell Physiol; 2021 Aug; 236(8):5676-5685. PubMed ID: 33400290 [TBL] [Abstract][Full Text] [Related]
3. IL-37 requires the receptors IL-18Rα and IL-1R8 (SIGIRR) to carry out its multifaceted anti-inflammatory program upon innate signal transduction. Nold-Petry CA; Lo CY; Rudloff I; Elgass KD; Li S; Gantier MP; Lotz-Havla AS; Gersting SW; Cho SX; Lao JC; Ellisdon AM; Rotter B; Azam T; Mangan NE; Rossello FJ; Whisstock JC; Bufler P; Garlanda C; Mantovani A; Dinarello CA; Nold MF Nat Immunol; 2015 Apr; 16(4):354-65. PubMed ID: 25729923 [TBL] [Abstract][Full Text] [Related]
4. Expression and function of IL-1R8 (TIR8/SIGIRR): a regulatory member of the IL-1 receptor family in platelets. Anselmo A; Riva F; Gentile S; Soldani C; Barbagallo M; Mazzon C; Feruglio F; Polentarutti N; Somma P; Carullo P; Angelini C; Bacci M; Mendolicchio GL; Voza A; Nebuloni M; Mantovani A; Garlanda C Cardiovasc Res; 2016 Sep; 111(4):373-84. PubMed ID: 27297888 [TBL] [Abstract][Full Text] [Related]
5. Regulation of CD18 stability by SIGIRR-modulated ubiquitination: new insights into the relationship between innate immune response and acute lung injury. Tian F; Lei J; Ni Y; Zhong D; Xie N; Ma J; Wang H; Si S; Wu Y; Jiang T FEBS J; 2023 May; 290(10):2721-2743. PubMed ID: 36527283 [TBL] [Abstract][Full Text] [Related]
6. IL-37 requires IL-18Rα and SIGIRR/IL-1R8 to diminish allergic airway inflammation in mice. Lunding L; Webering S; Vock C; Schröder A; Raedler D; Schaub B; Fehrenbach H; Wegmann M Allergy; 2015 Apr; 70(4):366-73. PubMed ID: 25557042 [TBL] [Abstract][Full Text] [Related]
7. Transcriptomic analysis reveals that IL-1R8/Sigirr is a novel macrophage migration regulator and suppresses macrophage proliferation through p38 MAPK signaling pathway. Guo J; Zhan X; Xu G; Mao C; Wei R Biomed Pharmacother; 2020 Apr; 124():109846. PubMed ID: 31978769 [TBL] [Abstract][Full Text] [Related]
8. SIGIRR promotes resistance against Pseudomonas aeruginosa keratitis by down-regulating type-1 immunity and IL-1R1 and TLR4 signaling. Huang X; Hazlett LD; Du W; Barrett RP J Immunol; 2006 Jul; 177(1):548-56. PubMed ID: 16785552 [TBL] [Abstract][Full Text] [Related]
9. The essential role of single Ig IL-1 receptor-related molecule/Toll IL-1R8 in regulation of Th2 immune response. Bulek K; Swaidani S; Qin J; Lu Y; Gulen MF; Herjan T; Min B; Kastelein RA; Aronica M; Kosz-Vnenchak M; Li X J Immunol; 2009 Mar; 182(5):2601-9. PubMed ID: 19234154 [TBL] [Abstract][Full Text] [Related]
10. Lipopolysaccharide decreases single immunoglobulin interleukin-1 receptor-related molecule (SIGIRR) expression by suppressing specificity protein 1 (Sp1) via the Toll-like receptor 4 (TLR4)-p38 pathway in monocytes and neutrophils. Ueno-Shuto K; Kato K; Tasaki Y; Sato M; Sato K; Uchida Y; Sakai H; Ono T; Suico MA; Mitsutake K; Tokutomi N; Kai H; Shuto T J Biol Chem; 2014 Jun; 289(26):18097-109. PubMed ID: 24821721 [TBL] [Abstract][Full Text] [Related]
11. Characterization of a long isoform of IL-1R8 (TIR8/SIGIRR). Vilia MG; Tocchetti M; Fonte E; Sana I; Muzio M Eur Cytokine Netw; 2017 Jun; 28(2):63-69. PubMed ID: 28840837 [TBL] [Abstract][Full Text] [Related]
12. Negative Effects of SIGIRR on TRAF6 Ubiquitination in Acute Lung Injury In Vitro. Tian F; Lu Q; Lei J; Ni Y; Xie N; Zhong D; Yang G; Si S; Jiang T J Immunol Res; 2020; 2020():5097920. PubMed ID: 33123603 [TBL] [Abstract][Full Text] [Related]
13. High IL-1R8 expression in breast tumors promotes tumor growth and contributes to impaired antitumor immunity. Campesato LF; Silva APM; Cordeiro L; Correa BR; Navarro FCP; Zanin RF; Marçola M; Inoue LT; Duarte ML; Molgora M; Pasqualini F; Massara M; Galante P; Barroso-Sousa R; Polentarutti N; Riva F; Costa ET; Mantovani A; Garlanda C; Camargo AA Oncotarget; 2017 Jul; 8(30):49470-49483. PubMed ID: 28533483 [TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide reduces USP13 stability through c-Jun N-terminal kinase activation in Kupffer cells. Yu F; Li Y; Ye Q; Miao J; Taleb SJ; Zhao Y; Zhao J J Cell Physiol; 2021 Jun; 236(6):4360-4368. PubMed ID: 33169399 [TBL] [Abstract][Full Text] [Related]
15. Characterization of SIGIRR/IL-1R8 Homolog from Zebrafish Provides New Insights into Its Inhibitory Role in Hepatic Inflammation. Feng W; Gu YF; Nie L; Guo DY; Xiang LX; Shao JZ J Immunol; 2016 Jul; 197(1):151-67. PubMed ID: 27206770 [TBL] [Abstract][Full Text] [Related]
16. USP13 mediates PTEN to ameliorate osteoarthritis by restraining oxidative stress, apoptosis and inflammation via AKT-dependent manner. Huang J; Ye Z; Wang J; Chen Q; Huang D; Liu H Biomed Pharmacother; 2021 Jan; 133():111089. PubMed ID: 33378983 [TBL] [Abstract][Full Text] [Related]
17. Interleukin-1alpha and HMGB1 mediate hippocampal dysfunction in SIGIRR-deficient mice. Costello DA; Watson MB; Cowley TR; Murphy N; Murphy Royal C; Garlanda C; Lynch MA J Neurosci; 2011 Mar; 31(10):3871-9. PubMed ID: 21389242 [TBL] [Abstract][Full Text] [Related]
18. Single immunoglobulin IL-1 receptor-related protein attenuates the lipopolysaccharide-induced inflammatory response in A549 cells. Feng T; Yunfeng N; Jinbo Z; Zhipei Z; Huizhong Z; Li L; Tao J; Yunjie W Chem Biol Interact; 2010 Feb; 183(3):442-9. PubMed ID: 19948160 [TBL] [Abstract][Full Text] [Related]
19. MiR-340 suppresses CCl4-induced acute liver injury through exerting anti-inflammation targeting Sigirr. Liu HH; Li AJ Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10687-10695. PubMed ID: 33155227 [TBL] [Abstract][Full Text] [Related]
20. USP13-mediated IRAK4 deubiquitination disrupts the pathological symptoms of lipopolysaccharides-induced sepsis. Wang Z; Jiang L; Zhang D; Chen D; Wang L; Xiao D Microbes Infect; 2021; 23(9-10):104867. PubMed ID: 34298177 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]